Compare FFBC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FFBC | VERA |
|---|---|---|
| Founded | 1863 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.0B |
| IPO Year | 2004 | 2021 |
| Metric | FFBC | VERA |
|---|---|---|
| Price | $34.49 | $41.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | $30.71 | ★ $81.30 |
| AVG Volume (30 Days) | 1.0M | ★ 2.3M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | ★ 10.83 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.67 | N/A |
| Revenue Next Year | $4.58 | $472.48 |
| P/E Ratio | $47.90 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.09 | $19.07 |
| 52 Week High | $35.00 | $56.05 |
| Indicator | FFBC | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 58.55 |
| Support Level | $29.32 | $40.87 |
| Resistance Level | $35.00 | $43.30 |
| Average True Range (ATR) | 0.71 | 2.72 |
| MACD | 0.01 | 0.17 |
| Stochastic Oscillator | 85.30 | 59.75 |
First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending, and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and non-interest-bearing accounts, time deposits, and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.